2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus …
HN Ginsberg, CJ Packard, MJ Chapman… - European heart …, 2021 - academic.oup.com
Recent advances in human genetics, together with a large body of epidemiologic,
preclinical, and clinical trial results, provide strong support for a causal association between …
preclinical, and clinical trial results, provide strong support for a causal association between …
[HTML][HTML] Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022
ОМ Драпкина, АВ Концевая, АМ Калинина… - Кардиоваскулярная …, 2022 - cyberleninka.ru
Члены Комитета экспертов подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of …
SM Grundy, NJ Stone, AL Bailey, C Beam… - Journal of the American …, 2019 - jacc.org
The recommendations listed in the present guideline are, whenever possible, evidence
based. An initial extensive evidence review, which included literature derived from research …
based. An initial extensive evidence review, which included literature derived from research …
Clinical review on triglycerides
U Laufs, KG Parhofer, HN Ginsberg… - European heart …, 2020 - academic.oup.com
Hypertriglyceridaemia is a common clinical problem. Epidemiologic and genetic studies
have established that triglyceride-rich lipoproteins (TRL) and their remnants as important …
have established that triglyceride-rich lipoproteins (TRL) and their remnants as important …
Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients
CDL Johannesen, MB Mortensen, A Langsted… - Journal of the American …, 2021 - jacc.org
Background In cholesterol guidelines, low-density lipoprotein (LDL) cholesterol remains the
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …
Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017
AA Faludi, MCO Izar, JFK Saraiva… - Arquivos brasileiros de …, 2017 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …
Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study
CDL Johannesen, A Langsted, MB Mortensen… - Bmj, 2020 - bmj.com
Objective To determine the association between levels of low density lipoprotein cholesterol
(LDL-C) and all cause mortality, and the concentration of LDL-C associated with the lowest …
(LDL-C) and all cause mortality, and the concentration of LDL-C associated with the lowest …
The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk
PB Sandesara, SS Virani, S Fazio… - Endocrine …, 2019 - academic.oup.com
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death
worldwide. Low-density lipoprotein cholesterol (LDL-C) is a well-established mediator of …
worldwide. Low-density lipoprotein cholesterol (LDL-C) is a well-established mediator of …